LiveSmart: Minimally Invasive Treatments Available in Battle against Colorectal Cancer, Pre-Cancerous Polyps

[This story was written by Joseph Choma, MD, Chief of Gastroenterology, and a Gastroenterologist/Advanced Endoscopist with Albany Gastroenterology Consultants and St. Peter’s Hospital Advanced Endoscopy and Hepatobiliary Center.]

While colorectal cancer remains the second leading cause of cancer-related deaths in the United States, tremendous progress has been made in recent years.

In fact, newly diagnosed cases and deaths due to colorectal cancer are on the decline. This is mostly thanks to increased awareness of the need for screening, and in turn, early detection and treatment of the disease.

The importance of screening for colorectal cancer has become even more apparent during the COVID-19 pandemic. National preventative colorectal cancer screening rates decreased significantly compared to before COVID. Estimates suggest that globally, between 2020 and 2023, because of COVID-19, approximately 1.2 million to 2 million cases of colorectal cancer screening, 8,346 to 12,894 cases of colorectal cancer diagnosis, and 6,113 to 9,301 cases of early-stage colorectal cancer diagnoses will be missed.

While there is still much work to be done, there is hope. With increased colorectal screening and state of the art treatment, we can detect cancer at earlier and curable stages, helping patients lead longer and healthier lives.

Minimally Invasive Endoscopic Treatment Options – ESD, EMR, and EFTR
Typically, when pre-cancerous polyps are detected during a screening colonoscopy, they are removed endoscopically. Until recently, larger polyps required surgical removal. Newer options for minimally invasive treatment, including endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and endoscopic full thickness resection (EFTR) offer patients the opportunity to be cured of large polyps without the need for surgery.

Some patients with early-stage cancer are also appropriate to be considered for endoscopic treatment as a definitive cure. When surgery is required, it can now often be performed with minimally-invasive laparoscopic or robotic techniques using small incisions.

If colorectal cancer is not detected at an early stage, additional treatment such as chemotherapy and/or radiation treatment may be needed. Depending on the stage, these treatments may be given prior to removal and at other times after removal of the tumor. Precise staging of tumors is very important and often obtained using endoscopic techniques and imaging tests such as CT, MRI and PET scans.

Advances in chemotherapy drugs and management of their side effects, as well as technological advances in radiation therapy including image-guided treatment, have improved colorectal cancer care and outcomes.

Better Outcomes
Evidence shows that clinical outcomes are improved in centers that perform higher numbers of endoscopic procedures and cancer surgery. St. Peter’s Hospital Advanced Endoscopy & Hepatobiliary Center is at the forefront of interventional endoscopic procedures. We offer access to cutting-edge technology and expertise to maximize diagnostic and therapeutic treatment options.

See original article

For more information, please visit us at albanygi.com and https://www.sphp.com/find-a-service-or-specialty/gastroenterology/advanced-endoscopy-center, or please call 518-533-5000.

Additional News & Events

LiveSmart: Minimally Invasive Treatments Available in Battle against Colorectal Cancer, Pre-Cancerous Polyps

The importance of screening for colorectal cancer has become even more apparent during the COVID-19 pandemic. National preventative colorectal cancer screening rates decreased significantly compared to before COVID. While there is still much work to be done, there is hope. With increased colorectal screening and state of the art treatment, we can detect cancer at earlier and curable stages, helping patients lead longer and healthier lives.

Read More »

Follow Us

Scroll to Top